USA Financial Formulas’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-7
Closed -$239 561
2023
Q3
$239 Hold
7
﹤0.01% 486
2023
Q2
$280 Hold
7
﹤0.01% 471
2023
Q1
$275 Buy
+7
New +$257 ﹤0.01% 411
2022
Q3
$0 Hold
7
﹤0.01% 432
2022
Q2
$0 Hold
7
﹤0.01% 458
2022
Q1
$0 Hold
7
﹤0.01% 511
2021
Q4
$0 Hold
7
﹤0.01% 504
2021
Q3
$0 Sell
7
-14,561
-100% -$898K ﹤0.01% 495
2021
Q2
$922K Buy
+14,568
New +$960K 0.77% 65
2020
Q1
Sell
-2,656
Closed -$150K 334
2019
Q4
$150K Sell
2,656
-39,202
-94% -$2.19M 0.06% 143
2019
Q3
$2.23M Buy
+41,858
New +$2.25M 0.87% 59
2016
Q2
Sell
-105,994
Closed -$6.53M 228
2016
Q1
$6.53M Buy
105,994
+36,631
+53% +$2.16M 2.08% 17
2015
Q4
$4.22M Buy
+69,363
New +$4.13M 1.71% 21

Other funds holding XRAY

USA Financial Formulas's XRAY Position: Q4 2023 in Review

USA Financial Formulas sold out of Dentsply Sirona (XRAY) in Q4 2023, closing a stake of 7 shares — an estimated $239 sold.

USA Financial Formulas first reported a position in XRAY in Q4 2015 and held it in 13 quarters. The position peaked at $6.53M in Q1 2016. 416 funds tracked by Wall St. Rank hold XRAY as of Q4 2023.

  • USA Financial Formulas reported no remaining Dentsply Sirona position as of Q4 2023 after selling out during the quarter.
  • USA Financial Formulas sold 7 Dentsply Sirona shares in Q4 2023, an estimated $239.
  • USA Financial Formulas first reported a position in Dentsply Sirona in Q4 2015 and held it in 13 quarters.
  • USA Financial Formulas's Dentsply Sirona position peaked at $6.53M in Q1 2016.
  • 416 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2023.

Based on USA Financial Formulas's 13F filing for Q4 2023, filed 7 Feb 2024.